These numbers reveal what's broken in your metabolism and inform which medication addresses your root problems
Biologic agents targeting specific inflammatory pathwaysincluding TNF- inhibitors (adalimumab, etanercept), IL-6 inhibitors (tocilizumab), T-cell costimulation modulators (abatacept), and B-cell depleting agents (rituximab)provide additional options for patients with inadequate response to conventional therapy
The injectable, which is aimed at adults struggling with excess weight and for adolescents aged 1217 over 60 kilograms (132 lbs), is the first and only generic GLP-1 currently available
Comparative effectiveness of the sodiumglucose cotransporter 2 inhibitor empagliflozin versus other antihyperglycemics on risk of major adverse kidney events
Ansai S, Mitsuhashi Y, Kondo S, et al